GlassScriptPhysician profile
Kyle Christopher Farley
NPI 1083008874
$5,486.12
in general payments reported to CMS, 2019-2025
44 companies · $550 in 2025
The $550 reported for 2025 was more than what 75% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $755 · 2020: $534 · 2021: $846 · 2022: $1,269 · 2023: $764 · 2024: $770 · 2025: $550.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,083.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,082.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $818.00 | 2021-2025 | |
| Novo Nordisk INC | $606.81 | 2019-2025 | Ozempic, Wegovy, Rybelsus |
| Astrazeneca Pharmaceuticals LP | $481.15 | 2019-2024 | Breztri, Airsupra |
| Boehringer Ingelheim Pharmaceuticals, INC. | $294.83 | 2021-2024 | Ofev |
| Pfizer INC. | $283.20 | 2019-2025 | |
| Lilly USA, LLC | $265.23 | 2022-2025 | Mounjaro, Jardiance, Zepbound |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $260.05 | 2019-2025 | Xifaxan |
| Merck Sharp & Dohme LLC | $205.71 | 2020-2024 | Verquvo, Gardasil 9, Vaxelis |
| Glaxosmithkline, LLC. | $200.86 | 2020-2025 | Arexvy, Shingrix, Trelegy Ellipta |
| Exact Sciences Corporation | $193.13 | 2023-2025 | Cologuard Collection Kit |
| E.R. Squibb & Sons, L.L.C. | $161.09 | 2019-2025 | Eliquis, Camzyos |
| Janssen Pharmaceuticals, INC | $144.26 | 2024 | Invega Sustenna, Spravato |
| Abbott Laboratories | $141.03 | 2022-2025 | Freestyle Libre 3 |
| Bayer Healthcare Pharmaceuticals INC. | $133.47 | 2021-2022 | |
| Amarin Pharma, INC. | $128.34 | 2019-2022 |
Show all 44 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kyle Farley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.